XFOR Covered Call Strategy
XFOR (X4 Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
X4 Pharmaceuticals, Inc. is a biopharmaceutical firm committed to the discovery, development, and commercialization of innovative therapies for uncommon immune system disorders. Its primary drug candidate, XOLREMDI (also known as mavorixafor), is an orally administered, small-molecule antagonist specifically designed to target the chemokine receptor CXCR4. This compound is currently undergoing Phase 3 clinical trials for the management of WHIM syndrome, a rare immunodeficiency characterized by symptoms such as warts, hypogammaglobulinemia, recurrent infections, and myelokathexis. To broaden its global presence, the company has entered into several licensing agreements: A partnership with Abbisko Therapeutics Co Ltd. grants rights for the manufacturing and distribution of XOLREMDI in mainland China, Taiwan, Hong Kong, and Macau. Another agreement with Norgine covers the development, production, and commercialization of mavorixafor across Europe, Australia, and New Zealand. Furthermore, X4 Pharmaceuticals holds a comprehensive agreement with Genzyme Corporation concerning the CXCR4 receptor, allowing for the development and commercialization of licensed compounds for all medical applications, including therapeutic, preventive, and diagnostic uses.
XFOR (X4 Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $379.2M, a beta of 0.37 versus the broader market, a 52-week range of 1.35-4.83, average daily share volume of 571K, a public-listing history dating back to 2017, approximately 143 full-time employees. These structural characteristics shape how XFOR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.37 indicates XFOR has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a covered call on XFOR?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
Current XFOR snapshot
As of June 29, 2026, spot at $4.21, ATM IV 23.70%, IV rank 1.45%, expected move 6.79%. The covered call on XFOR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.
Why this covered call structure on XFOR specifically: XFOR IV at 23.70% is on the cheap side of its 1-year range, which means a premium-selling XFOR covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 6.79% (roughly $0.29 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated XFOR expiries trade a higher absolute premium for lower per-day decay. Position sizing on XFOR should anchor to the underlying notional of $4.21 per share and to the trader's directional view on XFOR stock.
XFOR covered call setup
The XFOR covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With XFOR near $4.21, the first option leg uses a $4.42 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed XFOR chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 XFOR shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $4.21 | long |
| Sell 1 | Call | $4.42 | N/A |
XFOR covered call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
XFOR covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on XFOR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use covered call on XFOR
Covered calls on XFOR are an income strategy run on existing XFOR stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
XFOR thesis for this covered call
The market-implied 1-standard-deviation range for XFOR extends from approximately $3.92 on the downside to $4.50 on the upside. A XFOR covered call collects premium on an existing long XFOR position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether XFOR will breach that level within the expiration window. Current XFOR IV rank near 1.45% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on XFOR at 23.70%. As a Healthcare name, XFOR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to XFOR-specific events.
XFOR covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. XFOR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move XFOR alongside the broader basket even when XFOR-specific fundamentals are unchanged. Short-premium structures like a covered call on XFOR carry tail risk when realized volatility exceeds the implied move; review historical XFOR earnings reactions and macro stress periods before sizing. Always rebuild the position from current XFOR chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on XFOR?
- A covered call on XFOR is the covered call strategy applied to XFOR (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With XFOR stock trading near $4.21, the strikes shown on this page are snapped to the nearest listed XFOR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are XFOR covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the XFOR covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 23.70%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a XFOR covered call?
- The breakeven for the XFOR covered call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current XFOR market-implied 1-standard-deviation expected move is approximately 6.79%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on XFOR?
- Covered calls on XFOR are an income strategy run on existing XFOR stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current XFOR implied volatility affect this covered call?
- XFOR ATM IV is at 23.70% with IV rank near 1.45%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.